Akebia Therapeutics (AKBA) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.09
-0.06
-0.03
0

Details

Expected EPS
-0.071967
Actual EPS
-0.09
Surprise EPS
-0.02
Surprise Percent
+25.06%

Description

Akebia Therapeutics (AKBA) has reported earnings of -0.09 per share for Q2 2024.

0 Comments

Share your thoughts